Efficacy and safety of herbal bath for mild-to-moderate atopic dermatitis: A randomized, double-blind, placebo-controlled trial.
Duan Zhen Z, Cai Rui-Qi RQ, Shen Fan-Ling-Zi FL, Lu Jinrong J et al.
Previous studies have suggested the potential of a traditional Chinese herbal bath, known as Mushengshu (MSS), for alleviating atopic dermatitis (AD) symptoms, but high-quality evidence is lacking. This study evaluates the efficacy and safety of MSS combined with foundational therapies in patients with mild-to-moderate AD. A total of 66 patients with mild-to-moderate AD were enrolled between August and December 2025 and were randomly assigned in a 2:1 ratio to the MSS group (n = 44) or the placebo group (n = 22). Patients received MSS or placebo once daily for 4 months. Meanwhile, the desonide cream for mild AD and triamcinolone acetonide cream for moderate AD were combined with urea ointment and applied twice daily for 2 weeks. The primary outcome was the proportion of patients who achieved ≥50% improvement in their Eczema Area and Severity Index (EASI) score from baseline to week 4 (EASI 50). Secondary outcomes included the continuous change in EASI scores, EASI 75/90 response rates, visual analogue scale (VAS), Investigator's Global Assessment (IGA) and Dermatology Life Quality Index (DLQI), assessed at weeks 0, 1, 2, 4 and 16. Data analysis was performed in line with the intention-to-treat principle. The EASI 50 response rate at week 4 was significantly higher in the MSS group than in the placebo group (70.5% vs 45.5%, P < 0.05) and similar statistically significant improvements were observed in the EASI 75 and EASI 90 response rates (P < 0.05). Nevertheless, compared to the placebo group, the MSS group had significantly lower median scores in the EASI, VAS, IGA and DLQI and a higher EASI 90 response rate (70.5% vs 45.5%) than the placebo (P < 0.05), and there were no adverse events reported. The results suggest that MSS combined with foundational therapies may be a beneficial adjuvant treatment for mild-to-moderate AD, providing support for its incorporation into comprehensive disease management. International Traditional Medicine Clinical Trial Registry ITMCTR2025001206. Please cite this article as: Duan Z, Cai RQ, Shen FLZ, Lu JR, Xu QR, Zhang R, Gao XJ, Li B. Wang RP. Efficacy and safety of herbal bath for mild-to-moderate atopic dermatitis: A randomized, double-blind, placebo-controlled trial. J Integr Med. 2026; Epub ahead of print.